GL1X · GenesisL1 explorer

Research workbench

Crystal structure of taiwan cobra cardiotoxin A3 complexed with sulfogalactoceramide

Analyse Crystal structure of taiwan cobra cardiotoxin A3 complexed with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2BHI
Type
protein
Length
120 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cytotoxin 3
UniProt
P01444
Ligands
C10, SFT
Pockets
1 · best druggability 0.60

Structure

x-ray diffraction · 1 distinct chain · 0% helix, 40% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BCytotoxin 3protein600% helix, 40% strandP01444

Ligands and binding sites

  • C10 · Hexaethylene glycol monodecyl ether · ligand · 11 copies · chains A, B
  • SFT · Sulfogalactoceramide · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12740.600.7838C10

Interfaces

1 interface between chains.

  • A–B · 549 Ų buried · 2 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 disulfide (disulfide).

Compared structures

  • 2BHI · Crystal structure of Taiwan cobra cardiotoxin A3 complexed with sulfogalactoceramide · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.